We next examined CD133, which has been reported to be a cancer stem cell marker (Singh et al, 2003; Hermann et al, 2007; Ricci-Vitiani et al, 2007; Chearwae and Bright, 2008; Mizrak et al, 2008). Here, PROM1 is linked to cancer.